1,765
Views
8
CrossRef citations to date
0
Altmetric
Editorial

NK cells beat T cells at early breast cancer control

, , , ORCID Icon & ORCID Icon
Article: 1806010 | Received 20 Jul 2020, Accepted 31 Jul 2020, Published online: 23 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Melanie Bourgin, Oliver Kepp & Guido Kroemer. (2022) Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy. OncoImmunology 11:1.
Read now
Mingkai Gong, Xiangping Liu, Wu Yang, Hongming Song, Xian Zhao, Xiancheng Ai, Shuo Wang & Haibo Wang. (2021) Identification of a Lipid Metabolism-Associated Gene Signature Predicting Survival in Breast Cancer. International Journal of General Medicine 14, pages 9503-9513.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Takahiro Yamazaki, Erik Wennerberg, Michal Hensler, Aitziber Buqué, Jeffrey Kraynak, Jitka Fucikova, Xi Kathy Zhou, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria & Lorenzo Galluzzi. (2021) LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. OncoImmunology 10:1.
Read now

Articles from other publishers (4)

Qinghua Huang, Jianlan Mo, Huawei Yang, Yinan Ji, Rong Huang, Yan Liu & You Pan. (2023) Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer. BMC Cancer 23:1.
Crossref
Jitka Fucikova, Lenka Palova-Jelinkova, Vanessa Klapp, Peter Holicek, Tereza Lanickova, Lenka Kasikova, Jana Drozenova, David Cibula, Beatriz Álvarez-Abril, Elena García-Martínez, Radek Spisek & Lorenzo Galluzzi. (2022) Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer 8:5, pages 426-444.
Crossref
André E. Nel, Kuo-Ching Mei, Yu-Pei Liao & Xiangsheng Liu. (2022) Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano 16:4, pages 5184-5232.
Crossref
Benjamin Wolfson, Michelle R Padget, Jeffrey Schlom & James W Hodge. (2021) Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing. Journal for ImmunoTherapy of Cancer 9:7, pages e002258.
Crossref